Vicore Pharma Holding AB (publ) (STO:VICO)

Vicore Pharma Holding AB Ratios and Metrics

Market cap in millions SEK. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 2, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	2,815	3,181	1,982	1,584	1,465	999
Market Cap Growth	40.37%	60.49%	25.12%	8.13%	46.67%	-47.51%
Enterprise Value	1,647	2,345	1,602	1,033	1,295	552
Last Close Price	10.00	11.30	8.45	13.80	17.42	13.54
PS Ratio	737.56	833.44	18.13	-	-	-
PB Ratio	2.57	2.90	1.76	3.48	5.07	2.61
P/TBV Ratio	2.57	2.90	1.76	3.50	6.63	3.16
EV/Sales Ratio	-	614.46	14.65	-	-	-
Debt / Equity Ratio	-	-	-	-	0	0.00
Net Debt / Equity Ratio	-1.07	-1.07	-1.02	-1.06	-0.90	-0.97
Net Debt / EBITDA Ratio	2.60	2.60	6.15	1.52	0.92	1.28
Net Debt / FCF Ratio	3.12	3.12	7.01	1.93	0.87	1.40
Asset Turnover	0.00	0.00	0.13	-	-	-
Quick Ratio	9.99	9.99	16.13	11.86	5.69	5.67
Current Ratio	10.30	10.30	16.50	12.10	5.81	5.75
Return on Equity (ROE)	-42.92%	-42.92%	-21.28%	-83.53%	-85.79%	-80.37%
Return on Assets (ROA)	-23.34%	-23.34%	-13.99%	-47.99%	-45.54%	-42.76%
Return on Capital Employed (ROCE)	-41.10%	-41.10%	-16.80%	-70.20%	-98.60%	-76.10%
Earnings Yield	-16.96%	-15.01%	-8.51%	-19.63%	-19.69%	-29.68%
FCF Yield	-	-11.77%	-8.32%	-15.75%	-20.47%	-26.55%
Buyback Yield / Dilution	-75.33%	-75.33%	-41.72%	-33.71%	-3.64%	-28.44%

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.